Manage Account - Modern Medicine

Botox vs brand X: In the war on wrinkles, who will reign supreme?
Publish date: August 3, 2008
Source:

The stage is set for a rival to compete with Botox Cosmetic in the botulinum-toxin aesthetic-drug market. The FDA recently announced that it is reviewing Reloxin, a botulinum-toxin anti-wrinkle injectable for domestic approval.

The journal page you requested is now available only to registered Modern Medicine members.

Register Here

Registration is Free!
(and Takes Less than a Minute)

RegisterUS Physicians, click here
for express registration.

RegisterHealthcare Professionals,
click here

Modern Medicine Offers:
» Practice Management Advice
» CME / ICD-9 Coding / Formulary
» Patient Education Handouts
» Peer-reviewed Articles
» Conference Coverage, Email Alerts & More

Click Here to Watch the Tour

Already Registered?

Login Now

Login Email:Password:
Forgot Your Password?Remember me.
Source: Cosmetic Surgery Times, 8/3/2008
Click here